EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger

Armando Cevenini iD, Pasqualino De Antonellis iD, Laura Letizia Mazzarelli iD, Laura Sarno iD, Pietro D'Alessandro, Massimiliano Pellicano, Serena Salomè iD, Francesco Raimondi, Maurizio Guida, Giuseppe Maria Maruotti, Marco Miceli iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311554 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Armando Cevenini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, Epigenesis, Genetic, Virus Latency. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human cytomegalovirus (HCMV) is a herpesvirus (family) belonging to the beta herpesvirus subfamily that causes significant morbidity both in immunocompromised hosts (horizontal transmission) and during vertical transmission from mother to child. HCMV has the ability to establish a permanent latent infection with its host (even for decades), in which the DNA remains as a silent nuclear episome (latent phase) until reactivation after the appropriate conditions have occurred (lytic phase). The transition between the two phases (latent/lytic) is largely determined by the type of infected cell and the health status of the host, which ultimately corresponds to the epigenetic state of the infected cells. Lytic infection of the virus normally occurs in epithelial cells, endothelial cells, fibroblasts or macrophages, whereas the latent phase occurs when undifferentiated cells of the myeloid lineage, such as CD34+ hematopoietic progenitor cells, are infected. Epigenetic regulation of the viral genome begins with the formation of chromatin in the viral DNA just 30 min after infection and then evolves towards the latent or lytic phase. DNA viruses, including members of the herpesvirus family, are currently the subject of intense study regarding the role that epigenetics plays in controlling the viral life cycle, focusing primarily on the role of post-translational modifications (PTMs) of histones, as well as DNA methylation. Within the viral genome, nucleosomes are organized for the spatial/temporal expression of appropriate genes due to epigenetic modifications. Therefore, during the infection cycle, DNA chromatinization and chromatin modifications influence the expression of genes in the HCMV genome. This process is mediated by (i) enzymes called “writers”, which catalyze PTMs by adding chemical groups to proteins (acetylation, methylation, etc.); (ii) recruitment of specific transcription factors called “readers”, that bind to modified amino acid residues of proteins and act as interpreters of the PTM code; and (iii) “erasers”, enzymes that remove these modifications (e.g., HDACs). Indeed, recent advances in understanding the chromatin-based mechanisms of viral infections offer some promising strategies for therapeutic intervention that could be particularly useful in immunosuppressed recipients of transplants to avoid allograft rejection and infection by other opportunistic pathogens. In this review, we comprehensively examine the epigenetic regulation of the HCMV genome across distinct phases of viral infection, with particular attention to recent studies that significantly enriched the current knowledge about molecular mechanisms and future therapeutic perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsCytomegalovirusEpigenesis, GeneticVirus LatencyHumansDNA MethylationHistonesGenome, ViralGene Expression Regulation, Viral

Stichwörter der Autor:innen

epigeneticshistoneshuman cytomegalovirus (HCMV)latent phaselytic phase

Substanzen

Histones

Autor:innen und Institutionen

  • Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
  • CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145 Naples, Italy.
  • Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
  • Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
  • Division of Neonatology, Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
  • Regional Reference Center (CER) for Infectious Diseases in Obstetrics and Gynecology in Campania, 80131 Naples, Italy.

ORCID-Profile: Armando Cevenini, Pasqualino De Antonellis, Laura Letizia Mazzarelli, Laura Sarno, Serena Salomè, Marco Miceli

Zitieren

APA

Cevenini, A., De Antonellis, P., Mazzarelli, L. L., Sarno, L., D'Alessandro, P., Pellicano, M., Salomè, S., Raimondi, F., Guida, M., Maruotti, G. M., & Miceli, M. (2025). Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311554

Vancouver

Cevenini A, De Antonellis P, Mazzarelli LL, Sarno L, D'Alessandro P, Pellicano M, et al. Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311554

BibTeX
@article{Cevenini2025,
  author = {Cevenini, Armando and De Antonellis, Pasqualino and Mazzarelli, Laura Letizia and Sarno, Laura and D'Alessandro, Pietro and Pellicano, Massimiliano and Salomè, Serena and Raimondi, Francesco and Guida, Maurizio and Maruotti, Giuseppe Maria and Miceli, Marco},
  title = {Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311554}
}
Kostenlos starten →